CLINICAL_TRIALS
research
· 2025-07-24
Clinical Trial Update: Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections
Summary
Expanded access (compassionate use) for fosmanogepix is being offered to patients with serious or life-threatening invasive fungal infections, sponsored by Basi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Basilea Pharmaceutica | Conditions: Invasive Fungal Infections | Status: AVAILABLE